國立虎尾科技大學 |

Hepatitis C Virus II = Infection and Disease /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Hepatitis C Virus II/ edited by Tatsuo Miyamura, Stanley M. Lemon, Christopher M. Walker, Takaji Wakita.
Reminder of title:	Infection and Disease /
other author:	Miyamura, Tatsuo.
Description:	IX, 372 p. 25 illus., 23 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Hepatology. -
Online resource:	https://doi.org/10.1007/978-4-431-56101-9
ISBN:	9784431561019

Hepatitis C Virus II = Infection and Disease /
Hepatitis C Virus IIInfection and Disease /[electronic resource] :edited by Tatsuo Miyamura, Stanley M. Lemon, Christopher M. Walker, Takaji Wakita. - 1st ed. 2016. - IX, 372 p. 25 illus., 23 illus. in color.online resource.

Part I. Chronic Hepatitis C -- 1. Natural History of chronic hepatitis C (Jake Liang and Marc Ghany) -- 2. The Multifaceted Features of HCV Infection beyond the Liver (Kazuhiko Koike) -- 3. Hepatic Fibrosis in Hepatitis C (Melissa A. Sheiko and Hugo R. Rosen) -- 4. Hepatocellular Carcinoma and Hepatitis C Virus (Sheng-Han Wang, Shiou-Hwei Yeh, and Pei-Jer Chen) -- 5. HCV, Alcohol, and the Liver (Terence N. Bukong, Banishree Saha, and Gyongyi Szabo) -- 6. Extrahepatic Replication of HCV (Wen-Chi Su, Keigo Machida, and Michael M.C. Lai) -- Part II. HCV Infections in Special Populations -- 7. Hepatitis C virus infection in pregnancy and children (Jessica Wen, Samantha Ohmer, Jonathan Honegger) -- Part III. Approaches to Therapy -- 8. Host Genetics and Responses to Antiviral Therapy in Chronic Hepatitis C (Yasuhito Tanaka and Masashi Mizokami) -- 9. Viral Variation and Response to Therapy (Shinya Maekawa and Nobuyuki Enomoto) -- 10. HCV NS3/4A Protease Inhibitors and the Road to Effective Direct-acting Antiviral Therapies (Nicolas Tremblay, Alex Young Park, and Daniel Lamarre) -- 11. Modeling HCV Dynamics in Clinical Practice to Personalize Antiviral Therapy (Piero Colombatto, Ferruccio Bonino, Luigi Civitano, Filippo Oliveri, Gabriele Ricco, Sergio Iannazzo, and Maurizia R. Brunetto) -- Part IV. Prevention and Control of HCV Infection -- 12. Prophylactic Vaccines for the Hepatitis C Virus (Andrea L. Cox) -- 13. Global control of hepatitis C infection (Tatsuo Miyamura).

This book helps scientists, clinicians and other interested individuals understand recent clinical advances and challenges for the future. It covers many basic aspects of the pathogenesis of chronic hepatitis C, HCV infections in particular populations, approaches to therapy, and prevention and control of HCV Infection. The book provides a succinct review of the large amount of data generated by multiple groups over the past two decades that has revealed the natural history of HCV infection. Similarly, it summarizes current understanding of the origins of HCV-associated hepatocellular carcinoma, cirrhosis and hepatic fibrosis. Extra-hepatic manifestation and metabolic disorders related to HCV infection are described. In this volume, these clinically important aspects of HCV infection are comprehensively described. Highlights are description of newly developed direct- acting antivirals. The authors represent a worldwide distribution of leaders in the field reflecting the global nature of HCV infection. Based on recent data concerning the genetic- and geographical diversity of HCV, and increased global disease burden of HCV infection, challenges for global control of HCV infections are described.

ISBN: 9784431561019

Standard No.: 10.1007/978-4-431-56101-9doiSubjects--Topical Terms:

673859
Hepatology.

LC Class. No.: RC841-858.P35

Dewey Class. No.: 616.36

Hepatitis C Virus II = Infection and Disease /
LDR:04069nam a22003975i 4500 001 980289
003 DE-He213
005 20200706225703.0
007 cr nn 008mamaa
008 201211s2016 ja | s |||| 0|eng d
020 $a 9784431561019 $9 978-4-431-56101-9
024 7 $a 10.1007/978-4-431-56101-9 $2 doi
035 $a 978-4-431-56101-9
050 4 $a RC841-858.P35
072 7 $a MJJ $2 bicssc
072 7 $a MED031000 $2 bisacsh
072 7 $a MJJ $2 thema
082 0 4 $a 616.36 $2 23
245 1 0 $a Hepatitis C Virus II $h [electronic resource] : $b Infection and Disease / $c edited by Tatsuo Miyamura, Stanley M. Lemon, Christopher M. Walker, Takaji Wakita.
250 $a 1st ed. 2016.
264 1 $a Tokyo : $b Springer Japan : $b Imprint: Springer, $c 2016.
300 $a IX, 372 p. 25 illus., 23 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Part I. Chronic Hepatitis C -- 1. Natural History of chronic hepatitis C (Jake Liang and Marc Ghany) -- 2. The Multifaceted Features of HCV Infection beyond the Liver (Kazuhiko Koike) -- 3. Hepatic Fibrosis in Hepatitis C (Melissa A. Sheiko and Hugo R. Rosen) -- 4. Hepatocellular Carcinoma and Hepatitis C Virus (Sheng-Han Wang, Shiou-Hwei Yeh, and Pei-Jer Chen) -- 5. HCV, Alcohol, and the Liver (Terence N. Bukong, Banishree Saha, and Gyongyi Szabo) -- 6. Extrahepatic Replication of HCV (Wen-Chi Su, Keigo Machida, and Michael M.C. Lai) -- Part II. HCV Infections in Special Populations -- 7. Hepatitis C virus infection in pregnancy and children (Jessica Wen, Samantha Ohmer, Jonathan Honegger) -- Part III. Approaches to Therapy -- 8. Host Genetics and Responses to Antiviral Therapy in Chronic Hepatitis C (Yasuhito Tanaka and Masashi Mizokami) -- 9. Viral Variation and Response to Therapy (Shinya Maekawa and Nobuyuki Enomoto) -- 10. HCV NS3/4A Protease Inhibitors and the Road to Effective Direct-acting Antiviral Therapies (Nicolas Tremblay, Alex Young Park, and Daniel Lamarre) -- 11. Modeling HCV Dynamics in Clinical Practice to Personalize Antiviral Therapy (Piero Colombatto, Ferruccio Bonino, Luigi Civitano, Filippo Oliveri, Gabriele Ricco, Sergio Iannazzo, and Maurizia R. Brunetto) -- Part IV. Prevention and Control of HCV Infection -- 12. Prophylactic Vaccines for the Hepatitis C Virus (Andrea L. Cox) -- 13. Global control of hepatitis C infection (Tatsuo Miyamura).
520 $a This book helps scientists, clinicians and other interested individuals understand recent clinical advances and challenges for the future. It covers many basic aspects of the pathogenesis of chronic hepatitis C, HCV infections in particular populations, approaches to therapy, and prevention and control of HCV Infection. The book provides a succinct review of the large amount of data generated by multiple groups over the past two decades that has revealed the natural history of HCV infection. Similarly, it summarizes current understanding of the origins of HCV-associated hepatocellular carcinoma, cirrhosis and hepatic fibrosis. Extra-hepatic manifestation and metabolic disorders related to HCV infection are described. In this volume, these clinically important aspects of HCV infection are comprehensively described. Highlights are description of newly developed direct- acting antivirals. The authors represent a worldwide distribution of leaders in the field reflecting the global nature of HCV infection. Based on recent data concerning the genetic- and geographical diversity of HCV, and increased global disease burden of HCV infection, challenges for global control of HCV infections are described.
650 0 $a Hepatology. $3 673859
650 0 $a Virology. $3 644995
650 0 $a Infectious diseases. $3 1102043
650 0 $a Public health. $3 560998
650 2 4 $a Infectious Diseases. $3 668393
650 2 4 $a Public Health. $3 592982
700 1 $a Miyamura, Tatsuo. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1114441
700 1 $a Lemon, Stanley M. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 865296
700 1 $a Walker, Christopher M. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1271298
700 1 $a Wakita, Takaji. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1271299
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9784431560999
776 0 8 $i Printed edition: $z 9784431561002
776 0 8 $i Printed edition: $z 9784431567769
856 4 0 $u https://doi.org/10.1007/978-4-431-56101-9
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)